Compass Therapeutics, Inc. (CMPX)
0.7562
0.00 (0.00%)
USD |
NASDAQ |
Oct 29, 16:00
0.78
+0.02
(+3.15%)
After-Hours: 20:00
Compass Therapeutics Market Cap : 136.18M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 136.18M |
| October 28, 2026 | 136.92M |
| October 27, 2026 | 134.60M |
| October 26, 2026 | 134.56M |
| October 23, 2026 | 137.05M |
| October 22, 2026 | 144.34M |
| October 21, 2026 | 146.68M |
| October 20, 2026 | 150.07M |
| October 19, 2026 | 150.37M |
| October 16, 2026 | 154.88M |
| October 15, 2026 | 161.48M |
| October 14, 2026 | 158.30M |
| October 13, 2026 | 154.34M |
| October 12, 2026 | 168.83M |
| October 09, 2026 | 178.83M |
| October 08, 2026 | 177.10M |
| October 07, 2026 | 183.69M |
| October 06, 2026 | 179.75M |
| October 05, 2026 | 172.99M |
| October 02, 2026 | 154.28M |
| October 01, 2026 | 162.28M |
| September 30, 2026 | 187.29M |
| September 29, 2026 | 198.10M |
| September 28, 2026 | 199.90M |
| September 25, 2026 | 203.50M |
| Date | Value |
|---|---|
| September 24, 2026 | 204.40M |
| September 23, 2026 | 210.70M |
| September 22, 2026 | 223.31M |
| September 21, 2026 | 327.76M |
| September 18, 2026 | 342.17M |
| September 17, 2026 | 333.16M |
| September 16, 2026 | 329.56M |
| September 15, 2026 | 333.16M |
| September 14, 2026 | 352.97M |
| September 11, 2026 | 360.18M |
| September 10, 2026 | 369.18M |
| September 09, 2026 | 392.59M |
| September 08, 2026 | 397.99M |
| September 04, 2026 | 428.61M |
| September 03, 2026 | 426.81M |
| September 02, 2026 | 437.61M |
| September 01, 2026 | 416.00M |
| August 31, 2026 | 430.41M |
| August 28, 2026 | 432.21M |
| August 27, 2026 | 453.82M |
| August 26, 2026 | 437.61M |
| August 25, 2026 | 455.62M |
| August 24, 2026 | 432.21M |
| August 21, 2026 | 432.21M |
| August 20, 2026 | 425.01M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viking Therapeutics, Inc. | 3.425B |
| Capricor Therapeutics, Inc. | 385.26M |
| Ardelyx, Inc. | 772.36M |
| Biomea Fusion, Inc. | 45.14M |
| ARS Pharmaceuticals, Inc. | 363.94M |
Market Cap Related Metrics
| Price to Book Value | 0.8201 |
| Price | 0.7562 |
| Earnings Yield | -53.23% |